Intech Investment Management LLC Sells 26,250 Shares of Astrana Health, Inc. $ASTH

Intech Investment Management LLC lowered its position in Astrana Health, Inc. (NASDAQ:ASTH) by 42.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,971 shares of the company’s stock after selling 26,250 shares during the quarter. Intech Investment Management LLC owned approximately 0.06% of Astrana Health worth $991,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Diamond Hill Capital Management Inc. lifted its holdings in shares of Astrana Health by 33.0% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 361,264 shares of the company’s stock worth $10,242,000 after acquiring an additional 89,733 shares during the last quarter. Pacer Advisors Inc. purchased a new stake in shares of Astrana Health in the 3rd quarter valued at $5,157,000. SteelPeak Wealth LLC grew its holdings in shares of Astrana Health by 7.8% during the 3rd quarter. SteelPeak Wealth LLC now owns 579,937 shares of the company’s stock valued at $16,441,000 after purchasing an additional 41,761 shares during the last quarter. Squarepoint Ops LLC grew its holdings in shares of Astrana Health by 475.4% during the 2nd quarter. Squarepoint Ops LLC now owns 95,557 shares of the company’s stock valued at $2,377,000 after purchasing an additional 78,951 shares during the last quarter. Finally, Rhenman & Partners Asset Management AB raised its position in Astrana Health by 26.7% in the 2nd quarter. Rhenman & Partners Asset Management AB now owns 190,000 shares of the company’s stock worth $4,727,000 after purchasing an additional 40,000 shares during the period. 52.77% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. BTIG Research lowered their price target on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a research note on Monday, February 2nd. Barclays reduced their price objective on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a research note on Monday, November 24th. Weiss Ratings reissued a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. Zacks Research cut Astrana Health from a “hold” rating to a “strong sell” rating in a report on Tuesday, February 10th. Finally, TD Cowen reduced their price target on Astrana Health from $40.00 to $35.00 and set a “buy” rating on the stock in a research report on Monday, November 10th. Five equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $35.33.

Astrana Health Trading Down 0.6%

Shares of ASTH opened at $24.91 on Monday. The stock has a market capitalization of $1.40 billion, a P/E ratio of 54.15 and a beta of 0.91. Astrana Health, Inc. has a twelve month low of $18.08 and a twelve month high of $34.80. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.25. The firm has a fifty day simple moving average of $23.56 and a two-hundred day simple moving average of $26.15.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Monday, March 2nd. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.39. The firm had revenue of $950.53 million for the quarter, compared to analysts’ expectations of $930.46 million. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The company’s revenue for the quarter was up 42.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.15) earnings per share. On average, research analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.